Publications by authors named "Laura Bracci"

Claim this Profile
I
Isolation and phenotype analysis of tissue-resident lymphocytes from mouse colon.
Alessia Fiore, Michela Tozzi, Paola Rinzo, Daniele Macchia, Massimo Spada, Laura Bracci

Methods Cell Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration.
Michela Tozzi, Alessia Fiore, Sara Travaglione, Francesca Marcon, Gabriella Rainaldi, Laura Bracci

J Exp Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Laura Bracci

Nat Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Laura Bracci

Nat Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19.
Eleonora Aricò, Laura Bracci, Luciano Castiello, Francesca Urbani, Jean-Laurent Casanova

Cytokine Growth Factor Rev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory properties of CNF1 toxin from : implications for colorectal carcinogenesis.
Alessia Fabbri, Laura Bracci

Am J Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Eleonora Aricò, Luciano Castiello, Laura Bracci, Francesca Urbani, Flavia Lombardo

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies.
Laura Bracci, Alessia Fabbri, Manuela Del Cornò, Lucia Conti

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Laura Bracci, Alessandra Fragale, Lucia Gabriele, Federica Moschella

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models.
Maria Ciccolella, Sara Andreone, Jacopo Mancini, Paola Sestili, Donatella Negri, Laura Bracci

Cells· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models.
Donatella Negri, Paola Sestili, Martina Borghi, Maria Ciccolella, Laura Bracci

Methods Enzymol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
Eleonora Aricò, Laura Bracci, Luciano Castiello, Sandra Gessani, Filippo Belardelli

Cytokine Growth Factor Rev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.
Alessandra Rossi, Valeria Lucarini, Iole Macchia, Paola Sestili, Carla Buccione, Laura Bracci

Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of exosomes in colorectal cancer disease progression and response to therapy.
Laura Bracci, Francesco Lozupone, Isabella Parolini

Cytokine Growth Factor Rev· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of type I interferons to cytotoxic treatments of cancer.
Laura Bracci, Antonella Sistigu, Enrico Proietti, Federica Moschella

Cytokine Growth Factor Rev· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.
Valeria Lucarini, Carla Buccione, Giovanna Ziccheddu, Francesca Peschiaroli, Paola Sestili, Laura Bracci

J Invest Dermatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of current anticancer immunotherapies.
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Laura Bracci

Oncotarget· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David P Enot, Laura Bracci

Nat Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines for the detection of immunogenic cell death.
Oliver Kepp, Laura Senovilla, Ilio Vitale, Erika Vacchelli, Sandy Adjemian, Laura Bracci

Oncoimmunology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting dendritic cells in the development of cancer vaccines.
Laura Bracci, Imerio Capone, Federica Moschella, Enrico Proietti, Filippo Belardelli

Expert Rev Vaccines· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.
Antonella Sistigu, Sophie Viaud, Nathalie Chaput, Laura Bracci, Enrico Proietti

Semin Immunopathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
Silvia Lorenzi, Fabrizio Mattei, Antonella Sistigu, Laura Bracci, Francesca Spadaro

J Immunol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
Giovanna Schiavoni, Antonella Sistigu, Mara Valentini, Fabrizio Mattei, Paola Sestili, Laura Bracci

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.
Maurizio Provenzano, Giovanni Sais, Laura Bracci, Adrian Egli, Maurizio Anselmi

J Cell Mol Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFN regulate DC turnover in vivo.
Fabrizio Mattei, Laura Bracci, David F Tough, Filippo Belardelli, Giovanna Schiavoni

Eur J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis